Finance

Lists
Why is 7Z6 up 20.71%?
Dive Deeper
7Z6:FRA
Coegin Pharma AB
€0.17
+20.71%
(+0.029) 1D
Oct 19, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 7Z6...
Open
€0.18
High
€0.18
Low
€0.17
Avg. vol.
233.00
Volume
0.00
52-wk high
€0.66
52-wk low
€0.15
No. of employees
3
Open
€0.18
High
€0.18
Low
€0.17
Avg. vol.
233.00
Volume
0.00
52-wk high
€0.66
52-wk low
€0.15
No. of employees
3
News stories
From web sources and news partners
About Coegin Pharma AB
CEOTore Duvold | Tore Duvold | Jens Eriksson
Employees3
Founded2005
Headquarters-
SectorBiotechnology
Websitecoeginpharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
79.00K
292.00K
62.00K
Cost of goods sold
4.00K
837.00K
156.00K
208.00K
Cost of revenue
4.00K
837.00K
156.00K
208.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.33M
5.36M
4.15M
5.39M
Operating expense
4.05M
6.10M
4.89M
5.79M
Total operating expenses
4.06M
6.94M
5.05M
6.00M
Operating income
-4.06M
-6.86M
-4.75M
-5.94M
Other non operating income
-
1.00K
-19.00K
1.00K
EBT including unusual items
-4.06M
-6.88M
-4.83M
-5.92M
EBT excluding unusual items
-4.06M
-6.88M
-4.83M
-5.92M
Income tax expense
-
16.00K
-
-
Effective tax rate
-
-0.23%
-
-
Other operating expenses
-33.00K
-18.00K
12.00K
-349.00K
Net income
-4.06M
-6.90M
-4.83M
-5.92M
Net profit margin
-
-8,732.91%
-1,653.77%
-9,545.16%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
21.00K
Interest expense
-
-11.00K
-56.00K
-
Net interest expenses
-
-11.00K
-56.00K
21.00K
Depreciation and amortization charges
759.00K
760.00K
728.00K
749.00K
EBITDA
-3.30M
-6.10M
-4.03M
-5.19M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps